XML 60 R49.htm IDEA: XBRL DOCUMENT
v3.19.2

Development and License Agreements - Additional Information (Detail) € in Millions | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | --- | ---
Aug. 31, 2018 EUR (€) | Jun. 30, 2019 USD ($) | Jun. 30, 2018 USD ($) | Jun. 30, 2019 USD ($) | Jun. 30, 2019 EUR (€) | Jun. 30, 2018 USD ($) | Dec. 31, 2016 EUR (€) | Jun. 30, 2019 EUR (€) | Dec. 31, 2018 USD ($) | Dec. 31, 2018 EUR (€)
Licenses Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Payments made relating to the manufacturing of the products |  | $ 5,600,000 | $ 4,800,000 | $ 13,400,000 |  | $ 10,200,000 |  |  |  |
BARDA Agreement |  |  |  |  |  |  |  |  |  |
Licenses Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Committed fund receivable |  | 103,200,000 |  | 103,200,000 |  |  |  |  |  |
Committed fund receivable |  | 201,200,000 |  | $ 201,200,000 |  |  |  |  |  |
Period of agreement |  |  |  | 5 years | 5 years |  |  |  |  |
Accounts receivable of billed and unbilled amounts |  | 4,200,000 |  | $ 4,200,000 |  |  |  |  | $ 2,300,000 |
Cerus Corporation | BARDA Agreement |  |  |  |  |  |  |  |  |  |
Licenses Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Co-investment by the company |  |  |  | 5,000,000.0 |  |  |  |  |  |
Additional co-investment by the company |  |  |  | 9,600,000 |  |  |  |  |  |
Manufacturing and Supply Agreement | Fresenius |  |  |  |  |  |  |  |  |  |
Licenses Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Payments made based on the successful achievement of production volumes | € |  |  |  |  | € 8.6 |  |  |  |  |
Manufacturing and development payments | € |  |  |  |  |  |  | € 3.1 |  |  |
Remaining amount payable for manufacturing and development | € | € 5.5 |  |  |  |  |  |  |  |  |
Manufacturing and Supply Agreement | Fresenius | Manufacturing and Development Obligations - Current |  |  |  |  |  |  |  |  |  |
Licenses Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Accrual for manufacturing and development of entity products |  | $ 6,200,000 |  | $ 6,200,000 |  |  |  | € 5.5 | $ 5,900,000 | € 5.2
Manufacturing and Supply Agreement | Fresenius | Measurement Input, Discount Rate |  |  |  |  |  |  |  |  |  |
Licenses Agreements [Line Items] |  |  |  |  |  |  |  |  |  |
Manufacturing and development obligations, discount rate |  |  |  |  |  |  | 9.72 |  |  |

X
- Definition Accrual for manufacturing and development payment liability. + References No definition available. + Details
Name: | cers_AccrualForManufacturingAndDevelopmentPaymentLiability
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Additional co-Investment for collaborative agreement. + References No definition available. + Details
Name: | cers_AdditionalCoInvestmentForCollaborativeAgreement
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Base period maximum funding of collaborative agreement. + References No definition available. + Details
Name: | cers_BasePeriodMaximumFundingOfCollaborativeAgreement
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Co-investment for collaborative agreement. + References No definition available. + Details
Name: | cers_CoInvestmentForCollaborativeAgreement
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Licenses agreements. + References No definition available. + Details
Name: | cers_LicensesAgreementsLineItems
Namespace Prefix: | cers_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Manufacturing and development payment liability. + References No definition available. + Details
Name: | cers_ManufacturingAndDevelopmentPaymentLiability
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Option period maximum funding of collaborative agreement. + References No definition available. + Details
Name: | cers_OptionPeriodMaximumFundingOfCollaborativeAgreement
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Payment for manufacturing of entity products. + References No definition available. + Details
Name: | cers_PaymentForManufacturingOfEntityProducts
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payments for manufacturing and development cost. + References No definition available. + Details
Name: | cers_PaymentsForManufacturingAndDevelopmentCost
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Remaining amount payable for manufacturing and development payment liability. + References No definition available. + Details
Name: | cers_RemainingAmountPayableForManufacturingAndDevelopmentPaymentLiability
Namespace Prefix: | cers_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Term of collaborative agreement. + References No definition available. + Details
Name: | cers_TermOfCollaborativeAgreement
Namespace Prefix: | cers_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of input used to measure alternative investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_AlternativeInvestmentMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount to be collected within one year of the balance sheet date (or one operating cycle, if longer) from customers in accordance with the contractual provisions of long-term contracts or programs including amounts billed and unbilled as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3(c)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_ReceivablesLongTermContractsOrPrograms
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=cers_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=cers_CerusCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cers_ManufacturingAndSupplyAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=cers_FreseniusKabiAGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=cers_AccrualForManufacturingAndDevelopmentPaymentLiabilityCurrentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |